China Feihe IPO Valuation: Reasonable Compared to Peers but Cheap Compared to Market Deal Multiples
In our previous two insights on China Feihe’s IPO, we mainly focused on the industry, the company’s business model and its financials. This...
694 Views
China Feihe IPO: Valuation Is Good for You
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
647 Views
Mengniu (2319): Short Term Uncertainty
China Mengniu Dairy Co (2319 HK)submitted a bid to buy Bellamy's Australia (BAL AU) to increase its participation in the infant milk formula market...
708 Views
China Feihe IPO: Right Formula for Growth but There Could Be Risks
China Feihe (FEIHE HK), the largest domestic Infant Milk Formula (IMF) maker in China with a market share of 8.6% (in 2017) has filed for an IPO on...
1.1k Views
China Feihe IPO Preview: The Winning Formula?
China Feihe (FEIHE HK) is the leading player in the China IMF (infant milk formula) market as measured by retail sales value in 2018, according to...
796 Views